Tianjin Finder Chemical: difference between revisions
Diff·revision 16 → 17·09:17, 11 Jan 2025
Difference between revision 16 and revision 17 of Tianjin Finder Chemical. 5 lines changed; the page grew by 784 bytes.
| Revision 16 — 06:23, 3 Jan 2025 TallySheetTad (talk) label community tally as self-reported 4,483 bytes +33 | Revision 17 — 09:17, 11 Jan 2025 NAION_Noel (talk) restructure 5,267 bytes +784 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = Tianjin Finder Chemical Co., Ltd. | 2 | | name = Tianjin Finder Chemical Co., Ltd. |
| + | 3 | | image = facility.svg | |
| + | 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| 3 | | Legal name = Tianjin Finder Chemical Co., Ltd. | 5 | | Legal name = Tianjin Finder Chemical Co., Ltd. |
| 4 | | Trading name = TFC | 6 | | Trading name = TFC |
| ⋮ | ⋮ | ||
| 28 | Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance, and water on a minority of lots.{{r|reports}} Packaging descriptions have been consistent. | 30 | Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance, and water on a minority of lots.{{r|reports}} Packaging descriptions have been consistent. |
| 29 | 31 | ||
| + | 32 | Tianjin's port position appears in reports as relatively short and predictable transit, and reported customs handling has been unremarkable.{{r|reports}} Origin has been consistently described as China rather than a regional warehouse, which — whatever else it implies — means the certificate date and the dispatch date have generally been close, avoiding the storage-interval gap described at [[Nantong Guangyuan Chemical]].{{r|usp1503}} | |
| + | 33 | ||
| 30 | == References == | 34 | == References == |
| 31 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 34 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 38 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 35 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 40 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 36 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 41 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 37 | 42 |